Lucid Diagnostics (LUCD)

• Market cap: $182M
• 1 day: -4.69%
• 5 days: 7.03%
• 1 month: -11.75%
• 3 months: -11.75%
• 6 months: -21.88%
• Year to date: -14.9%
• 1 year: -3.72%
• 5 years: -91.9%
• 10 years: -91.9%
• Sector: Healthcare
• Industry: Medical Devices

About: Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Employees: 82